Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma

Transfusion

Volumn 44, Issue 2, 2004, Pages 294-304

  George, James N ^a   Li, Xiaoning ^b   McMinn, Jay R ^b   Terrell, Deirdra R ^b   Vesely, Sara K ^b   Selby, George B ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOPSY; CAUSE OF DEATH; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE; FRAGMENTATION REACTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MORTALITY; PATHOGENESIS; PLASMAPHERESIS; REVIEW; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 1242322066     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.00700.x     Document Type: Review

References (81)

1. Daly AS, Xenocostas A, Lipton JH. Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002;30:709-15.
2. Allford SL, Bird JM, Marks DI. Thrombotic thrombocytopenic purpura following stem cell transplantation. Leuk Lymphoma 2002;43:1921-6.
3. McLeod BC. Thrombotic microangiopathies in bone marrow and organ transplant recipients. J Clin Apheresis 2002;17:118-23.
4. Elliott MA, Nichols WL, Plumhoff EA, et al. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review. Mayo Clin Proc 2003;78:421-30.
5. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000;96:1223-9.
6. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325:393-7.
7. Rizvi MA, Vesely SK, George JN, et al. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2000;40:896-901.
8. McMinn JR, Thomas IA, Terrell DR, et al. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: an additional study of 78 consecutive patients. Transfusion 2003;43:415-6.
9. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997;126:376-80.
10. Atkinson K, Biggs JC, Hayes J, et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 1983;54:59-67.
11. Shulman H, Striker G, Deeg HJ, et al. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 1981;305:1392-5.
12. Laszik Z, Silva F. Hemolytic-uremic syndrome, thrombotic thrombocytopenia purpura, and systemic sclerosis (systemic scleroderma). In: Jennett JC, Olson JL, Schwartz MM, et al., editors. Heptinstall's pathology of the kidney. Vol 5. Philadelphia: Lippincott-Raven; 1998:1003-57.
13. Ruutu T, Hermans J, Niederwieser D, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002;118:1112-9.
14. Pihusch R, Salat C, Schmidt E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Bone Marrow Transplant 2002;74:1303-9.
15. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marow transplantation. Blood 1989;73:2018-24.
16. Iacopino P, Pucci G, Arcese W, et al. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Bone Marrow Transplant 1999;24:47-51.
17. Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247-53.
18. Dua A, Zeigler ZR, Shadduck RK, et al. Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series. J Clin Apheresis 1996;11:176-84.
19. Zeigler ZR, Shadduck RK, Nath R, et al. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow-associated thrombotic microangiopathy. Bone Marrow Transplant 1996;17:81-6.
20. Zeigler Z, Rosenfeld CS, Andrews DF III, et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 1996;53:213-20.
21. Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, et al. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion 2003;43:78-84.
22. Guinan EC, Tarbell NJ, Niemeyer CM, et al. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988;72:451-5.
23. Antignac C, Gubler MC, Leverger G, et al. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 1989;35:1336-44.
24. Rabinowe SN, Soiffer RJ, Tarbell NJ, et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991;77:1837-44.
25. Kondo M, Kojima S, Horibe K, et al. Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies. Bone Marrow Transplant 1998;21:281-6.
26. Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogenic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998;22:351-7.
27. Teruya J, Styler M, Verde S, et al. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apheresis 2001;16:169-74.
28. Arai S, Allan C, Streiff M, et al. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy. Hematol J 2001;2:292-9.
29. Juckett M, Perry EH, Daniels BS, et al. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991;7:405-9.
30. Chappell ME, Keeling DM, Prentice HG, et al. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 1988;3:339-47.
31. Srivastava A, Gottileb D, Bradstock KF. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;15:863-7.
32. Ghany AM, Tutschka PJ, McGhee RM, et al. Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy. Transplantation 1991;52:310-5.
33. Smith RE, Berg DD. Coagulation defects in cyclosporine A treated allogeneic bone marrow transplant patients. Am J Hematol 1988;28:137-40.
34. Llamas P, Romero R, Cabrera R, et al. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange? Bone Marrow Transplant 1997;20:305-6.
35. Tezcan H, Zimmer W, Fenstermaker R, et al. Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506. Bone Marrow Transplant 1998;21:105-9.
36. Gharpure VS, Devine SM, Holland HK, et al. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. Bone Marrow Transplant 1995;16:715-6.
37. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994;46:1443-58.
38. Spruce W, Forman S, Blume K, et al. Hemolytic uremic syndrome after bone marrow transplantation. Acta Haematol 1982;67:206-10.
39. Cohen H, Bull A, Seddon A, et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol 1989;43:207-14.
40. Chandra M, McVicar M, Susin M, et al. Renal failure associated with hemolytic uremic syndrome (HUS): a complication of bone marrow transplantation (BMT). Kidney Int 1989;35:223.
41. Bocher WO, Schirmacher P, Lohr HF, et al. Hepatic manifestation of hemolytic uremic syndrome in an allogeneic bone marrow transplant recipient. Z Gastroenterol 1995;33:543-5.
42. Kuga T, Kohda K, Hirayama Y, et al. Pulmonary venoocclusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia. Int J Hematol 1996;64:143-50.
43. Chemnitz J, Fuchs M, Blau W, et al. Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation. Ann Hematol 2000;79:527-9.
44. Berthou C, Devergie A, D'Agay MF, et al. Late vascular complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1991;79:335-44.
45. Zomas A, Saso R, Powles R, et al. Red cell fragmentation (schistocytosis) after bone marrow transplantation. Bone Marrow Transplant 1998;22:777-80.
46. Roy V, Rizvi MA, Vesely SK, et al. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001;27:641-6.
47. Kanamori H, Takaishi Y, Takabayashi M, et al. Clinical significance of fragmented red cells after allogeneic bone marrow transplantation. Int J Hematol 2003;77:180-4.
48. Weisdorf DJ. Complications after stem cell transplantation. In: Hoffman R, Benz EJ, Shattil SJ, et al., editors. Hematology: basic principles and practice. Vol. 3. New York: Churchill Livingstone; 2000:1715-27.
49. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003;102:827-33.
50. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003;101:407-14.
51. Robboy SJ, Salisbury K, Ragsdale B, et al. Mechanism of Aspergillus-induced microangiopathic hemolytic anemia. Arch Intern Med 1971;128:790-3.
52. Grigg A, Clouston D. Disseminated fungal infection and early onset microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;15:795-7.
53. Maslo C, Peraldi MN, Desenclos JC, et al. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997;24:350-5.
54. Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient - a new treatment strategy. Transplantation 1998;65:1645-8.
55. Humblot S, Martin T, Pasquali JL, et al. Blood coagulation disorders during primary cytomegalovirus infection. Arch Intern Med 2001;161:2149-50.
56. Fassas AB, Buddharaju LN, Rapoport A, et al. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leuk Lymphoma 2001;42:801-4.
57. Matsuda Y, Hara J, Miyoshi H, et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous marrow transplantation in young children. Bone Marrow Transplant 1999;24:919-23.
58. Kok RHJ, Wolfhagen MJHM, Klosters G. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin Infect Dis 2001;32:311-2.
59. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994;14:495-504.
60. Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
61. Tsai HM, Lian ECY. Antibodies to von-Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
62. Bianchi V, Robles R, Alberio L, et al. Von Willebrand factor-cleaving protease (ADAMTS 13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 2002;100:710-3.
63. van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, throm-botic thrombocytopenic purpura. Blood 1999;93:3798-802.
64. Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;101:60-8.
65. Mannucci PM, Canciani MT, Forza I, et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001;98:2730-5.
66. Sniecinski IJ, O'Donnell MR. Hemolytic complications of hematopoietic cell transplantation. In: Thomas ED, Blume K, Forman SJ, editors. Hematopoietic cell transplantation. Vol. 2. Malden (MA): Blackwell; 1999:674-84.
67. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966;45:139-59.
68. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature. Medicine 1981;60:413-28.
69. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch Intern Med 1925;36:89-93.
70. Clark WF, Rock GA, Buskard N, et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 1999;131:453-62.
71. Clark WF, Garg AX, Blake PG, et al. Effect of awareness of a randomized controlled trial on use of experimental therapy. JAMA 2003;290:1351-5.
72. Devine SM, Adkins DR, Khoury H, et al. Recent advances in allogeneic hematopoietic stem cell transplantation. J Lab Clin Med 2003;141:7-32.
73. Zaia JA. Cytomegalovirus infections. In: Thomas ED, Blume K, Forman SJ, eds. Hematopoietic cell transplantation. Vol. 2. Malden (MA): Blackwell; 1999:560-83.
74. Tschuchnigg M, Bradstock KF, Koutts J, et al. A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990;5:61-3.
75. Silva VA, Frei-Lahr D, Brown RA, et al. Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apheresis 1991;6:16-20.
76. Sarode R, McFarland JG, Flomenberg N, et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1995;16:271-5.
77. Natazuka T, Kajimoto K, Ogawa R, et al. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies. Bone Marrow Transplant 1998;21:815-9.
78. Takatsuka H, Takemoto Y, Okamoto T, et al. Thrombotic microangiopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 1999;24:303-6.
79. Uderzo C, Fumagalli M, De Lorenzo P, et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 2000;26:1005-9.
80. Fuge R, Bird J, Fraser A, et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 2001;113:58-64.
81. Daly AS, Hasegawa WS, Lipton JH, et al. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acure graft-versus-host disease and venoocclusive disease of the liver. Transfus Apheresis Sci 2002;27:3-12.